Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.

Source:http://linkedlifedata.com/resource/pubmed/id/15790953

Circ. Res. 2005 Apr 29 96 8 904-12

Download in:

View as

General Info

PMID
15790953